Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas

BACKGROUND. Outcomes vary among patients with radioiodine refractory (RR) differentiated thyroid cancer (DTC). The prognostic factors for survival are not well-known, resulting in difficulty in selecting patients for new targeted therapies. We assessed overall survival (OS) and cancer-specific survi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Wassermann, Johanna, Bernier, Marie-Odile, Spano, Jean-Philippe, Lepoutre-Lussey, Charlotte, Buffet, Camille, Simon, Jean-Marc, Ménégaux, Fabrice, Tissier, Frédérique, Leban, Monique, Leenhardt, Laurence
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Endocrinology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709201/
https://ncbi.nlm.nih.gov/pubmed/26675742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados